Oronasal mask versus helmet in acute hypercapnic respiratory failure

Lara Pisani, Chiara Mega, Rosanna Vaschetto, Andrea Bellone, Raffaele Scala, Roberto Cosentini, Muriel Musti, Manuela Del Forno, Mario Grassi, Luca Fasano, Paolo Navalesi, Stefano Nava

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The choice of the interface for noninvasive ventilation (NIV) is a key factor in NIV success. We hypothesised that a new helmet specifically design to improve performance in hypercapnic patients would be clinically equivalent to a standard oronasal mask. In a multicentre, short-term, physiological, randomised trial in chronic obstructive pulmonary disease patients facing an acute hypercapnic respiratory failure episode, we compared the changes in arterial blood gases (ABGs) and tolerance score obtained using the helmet or mask, and, as secondary end-points, dyspnoea, vital signs, early NIV discontinuation and rate of intubation. 80 patients were randomly assigned to receive NIV either with the helmet (n=39) or mask (n=41), using an intensive care unit ventilator. Compared with baseline, in the first 6 h, NIV improved ABGs, dyspnoea and respiratory rate (p

Original languageEnglish
Pages (from-to)691-699
Number of pages9
JournalEuropean Respiratory Journal
Volume45
Issue number3
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Noninvasive Ventilation
Head Protective Devices
Masks
Respiratory Insufficiency
Dyspnea
Gases
Vital Signs
Mechanical Ventilators
Respiratory Rate
Intubation
Chronic Obstructive Pulmonary Disease
Intensive Care Units

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this

Pisani, L., Mega, C., Vaschetto, R., Bellone, A., Scala, R., Cosentini, R., ... Nava, S. (2015). Oronasal mask versus helmet in acute hypercapnic respiratory failure. European Respiratory Journal, 45(3), 691-699. https://doi.org/10.1183/09031936.00053814

Oronasal mask versus helmet in acute hypercapnic respiratory failure. / Pisani, Lara; Mega, Chiara; Vaschetto, Rosanna; Bellone, Andrea; Scala, Raffaele; Cosentini, Roberto; Musti, Muriel; Forno, Manuela Del; Grassi, Mario; Fasano, Luca; Navalesi, Paolo; Nava, Stefano.

In: European Respiratory Journal, Vol. 45, No. 3, 01.03.2015, p. 691-699.

Research output: Contribution to journalArticle

Pisani, L, Mega, C, Vaschetto, R, Bellone, A, Scala, R, Cosentini, R, Musti, M, Forno, MD, Grassi, M, Fasano, L, Navalesi, P & Nava, S 2015, 'Oronasal mask versus helmet in acute hypercapnic respiratory failure', European Respiratory Journal, vol. 45, no. 3, pp. 691-699. https://doi.org/10.1183/09031936.00053814
Pisani L, Mega C, Vaschetto R, Bellone A, Scala R, Cosentini R et al. Oronasal mask versus helmet in acute hypercapnic respiratory failure. European Respiratory Journal. 2015 Mar 1;45(3):691-699. https://doi.org/10.1183/09031936.00053814
Pisani, Lara ; Mega, Chiara ; Vaschetto, Rosanna ; Bellone, Andrea ; Scala, Raffaele ; Cosentini, Roberto ; Musti, Muriel ; Forno, Manuela Del ; Grassi, Mario ; Fasano, Luca ; Navalesi, Paolo ; Nava, Stefano. / Oronasal mask versus helmet in acute hypercapnic respiratory failure. In: European Respiratory Journal. 2015 ; Vol. 45, No. 3. pp. 691-699.
@article{f791bbb008ec4d9084920bdd5abe0ce9,
title = "Oronasal mask versus helmet in acute hypercapnic respiratory failure",
abstract = "The choice of the interface for noninvasive ventilation (NIV) is a key factor in NIV success. We hypothesised that a new helmet specifically design to improve performance in hypercapnic patients would be clinically equivalent to a standard oronasal mask. In a multicentre, short-term, physiological, randomised trial in chronic obstructive pulmonary disease patients facing an acute hypercapnic respiratory failure episode, we compared the changes in arterial blood gases (ABGs) and tolerance score obtained using the helmet or mask, and, as secondary end-points, dyspnoea, vital signs, early NIV discontinuation and rate of intubation. 80 patients were randomly assigned to receive NIV either with the helmet (n=39) or mask (n=41), using an intensive care unit ventilator. Compared with baseline, in the first 6 h, NIV improved ABGs, dyspnoea and respiratory rate (p",
author = "Lara Pisani and Chiara Mega and Rosanna Vaschetto and Andrea Bellone and Raffaele Scala and Roberto Cosentini and Muriel Musti and Forno, {Manuela Del} and Mario Grassi and Luca Fasano and Paolo Navalesi and Stefano Nava",
year = "2015",
month = "3",
day = "1",
doi = "10.1183/09031936.00053814",
language = "English",
volume = "45",
pages = "691--699",
journal = "European Journal of Respiratory Diseases",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "3",

}

TY - JOUR

T1 - Oronasal mask versus helmet in acute hypercapnic respiratory failure

AU - Pisani, Lara

AU - Mega, Chiara

AU - Vaschetto, Rosanna

AU - Bellone, Andrea

AU - Scala, Raffaele

AU - Cosentini, Roberto

AU - Musti, Muriel

AU - Forno, Manuela Del

AU - Grassi, Mario

AU - Fasano, Luca

AU - Navalesi, Paolo

AU - Nava, Stefano

PY - 2015/3/1

Y1 - 2015/3/1

N2 - The choice of the interface for noninvasive ventilation (NIV) is a key factor in NIV success. We hypothesised that a new helmet specifically design to improve performance in hypercapnic patients would be clinically equivalent to a standard oronasal mask. In a multicentre, short-term, physiological, randomised trial in chronic obstructive pulmonary disease patients facing an acute hypercapnic respiratory failure episode, we compared the changes in arterial blood gases (ABGs) and tolerance score obtained using the helmet or mask, and, as secondary end-points, dyspnoea, vital signs, early NIV discontinuation and rate of intubation. 80 patients were randomly assigned to receive NIV either with the helmet (n=39) or mask (n=41), using an intensive care unit ventilator. Compared with baseline, in the first 6 h, NIV improved ABGs, dyspnoea and respiratory rate (p

AB - The choice of the interface for noninvasive ventilation (NIV) is a key factor in NIV success. We hypothesised that a new helmet specifically design to improve performance in hypercapnic patients would be clinically equivalent to a standard oronasal mask. In a multicentre, short-term, physiological, randomised trial in chronic obstructive pulmonary disease patients facing an acute hypercapnic respiratory failure episode, we compared the changes in arterial blood gases (ABGs) and tolerance score obtained using the helmet or mask, and, as secondary end-points, dyspnoea, vital signs, early NIV discontinuation and rate of intubation. 80 patients were randomly assigned to receive NIV either with the helmet (n=39) or mask (n=41), using an intensive care unit ventilator. Compared with baseline, in the first 6 h, NIV improved ABGs, dyspnoea and respiratory rate (p

UR - http://www.scopus.com/inward/record.url?scp=84923862727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923862727&partnerID=8YFLogxK

U2 - 10.1183/09031936.00053814

DO - 10.1183/09031936.00053814

M3 - Article

C2 - 25504992

AN - SCOPUS:84923862727

VL - 45

SP - 691

EP - 699

JO - European Journal of Respiratory Diseases

JF - European Journal of Respiratory Diseases

SN - 0903-1936

IS - 3

ER -